Skip to main content

Day: July 16, 2020

Vaccines Market to Reach USD 104.87 Billion by 2027; Introduction of World’s First Malaria Vaccine in Malawi to Lighten Business Possibilities, states Fortune Business Insights™

Pune, July 16, 2020 (GLOBE NEWSWIRE) — The global vaccines market size is expected to reach USD 104.87 billion by 2027, exhibiting a CAGR of 10.7% during the forecast period. The ongoing clinical trials for COVID-19 vaccine will have a tremendous impact on the global market during the forecast period, states Fortune Business Insights in a report, titled “Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases (Hepatitis, Influenza, Human Papillomavirus, Measles/Mumps/Rubella, Rotavirus, Herpes Zoster, and Others) and Bacterial Diseases (Meningococcal Disease, Pneumococcal Disease, Diphtheria/Tetanus/Pertussis, and Others)), By Age Group (Pediatric and Adults),...

Continue reading

ISO Introduces Optional Endorsement for Damage to Underground Utility Lines

Jersey City, NJ, July 16, 2020 (GLOBE NEWSWIRE) — ISO, a Verisk (Nasdaq:VRSK) business, has launched a new homeowners endorsement to address damage to underground utility lines, a risk that isn’t always handled by municipalities or covered in standard homeowners insurance policies.The new endorsement for the ISO Homeowners Program can be used to provide coverage related to underground pipes, wires, and some buried equipment from a range of causes, including explosions, tree root growth, and wear and tear.“Claims arising from buried utilities often come as a surprise because deterioration is hidden until a loss of service occurs,” said Doug Caccese, president of ISO Personal Lines. “Excavating the line, fixing or replacing it, and repairing related damage can cost thousands of dollars. Our new endorsement is the kind of value-added...

Continue reading

RAPALA VMC CORPORATION’S HALF YEAR REPORT H1/2020: NET SALES AND PROFITABILITY DECREASED FOLLOWING THE COVID-19 PANDEMIC; SUCCESSFUL MITIGATION RESULTED IN IMPROVED OPERATING CASH FLOW AND SIGNIFICANT REDUCTION IN INVENTORIES AND NET DEBT

Rapala VMC CorporationHalf Year Financial ReportJuly 16, 2020 at 5:00 p.m.RAPALA VMC CORPORATION’S HALF YEAR REPORT H1/2020: NET SALES AND PROFITABILITY DECREASED FOLLOWING THE COVID-19 PANDEMIC; SUCCESSFUL MITIGATION RESULTED IN IMPROVED OPERATING CASH FLOW AND SIGNIFICANT REDUCTION IN INVENTORIES AND NET DEBTJanuary-June (H1) in brief:Net sales were 117.1 MEUR, down 17% from previous year (141.2). With comparable exchange rates sales were 17% down from previous year.Operating profit was -0.8 MEUR (11.4).Comparable operating profit* was 4.2 MEUR (12.0).Earnings per share was -0.12 EUR (0.17).Cash flow from operations was 13.4 MEUR (11.5).Inventories were 83.5 MEUR (108.6), down 23%.Net interest-bearing debt was 63.5 MEUR (104.1)Short-term outlook: End-consumer demand is currently on a good level in main markets, but it is still impossible...

Continue reading

RAPALA VMC OYJ:N PUOLIVUOSIKATSAUS H1 2020: MYYNTI JA KANNATTAVUUS LASKIVAT COVID-19 PANDEMIAN SEURAUKSENA; ONNISTUNEET SOPEUTUSTOIMENPITEET PARANSIVAT LIIKETOIMINNAN NETTORAHAVIRTAA SEKÄ LASKIVAT MERKITTÄVÄSTI VARASTOA JA NETTOVELKAA

Rapala VMC OyjPuolivuosikatsaus16.7.2020 klo 17.00RAPALA VMC OYJ:N PUOLIVUOSIKATSAUS H1 2020: MYYNTI JA KANNATTAVUUS LASKIVAT COVID-19 PANDEMIAN SEURAUKSENA; ONNISTUNEET SOPEUTUSTOIMENPITEET PARANSIVAT LIIKETOIMINNAN NETTORAHAVIRTAA SEKÄ LASKIVAT MERKITTÄVÄSTI VARASTOA JA NETTOVELKAA

Continue reading

Dorman Announces More Than 200 New Products, Including First-to-Aftermarket Steering Shafts and Nitrogen Suspension Compressors

Highlights:New exclusive steering shafts for more than 10 million General Motors vehiclesNew upgraded OE FIX nitrogen suspension compressors for 1.6 million Ram trucksNew complete, labor-saving windshield wiper motor and linkage assemblies for millions of popular vehicles on the road todayCOLMAR, Pa., July 16, 2020 (GLOBE NEWSWIRE) — Dorman Products, Inc. (NASDAQ:DORM) is announcing today the release of more than 200 new automotive repair products, giving professional installers and vehicle owners greater freedom to fix cars and trucks with innovative solutions designed to help them save time and money.Dorman’s featured releases this month are three first-to-aftermarket steering shafts that fit more than 10 million Chevrolet, GMC and Cadillac trucks and SUVs (425-130, 425-131 and 425-132).1 Like all Dorman’s steering shafts, these...

Continue reading

Refractories Market Size to Reach USD 42.30 Billion by 2027; Increasing Investments in Development of Efficient Products with Improved Properties will Aid Growth, says Fortune Business Insights™

Pune, July 16, 2020 (GLOBE NEWSWIRE) — The global refractories market size is projected to reach USD 42,308.2 million by the end of 2027. The increasing product applications across diverse industry verticals will emerge in favor of market growth. According to a report published by Fortune Business Insights, titled “Refractories Market Size, Share & Industry Analysis, By Form (Bricks & Shaped and Monolithics & Unshaped), By Product (Clay and Non-Clay), By Alkalinity (Acidic & Neutral and Basic), By End-Use Industry (Iron & Steel, Non-Ferrous Metals, Glass, Cement, and Others), and Regional Forecast, 2020-2027,” the market was worth USD 32,069.5 million in 2019 and will exhibit a CAGR of 3.6% during the forecast period, 2020-2027.We are taking continuous efforts to help your business sustain and grow during...

Continue reading

A88CBD™ Announces Partnership with Leading National Natural CPG Agency C.A. Fortune

SCOTTSDALE, Ariz., July 16, 2020 (GLOBE NEWSWIRE) — The Alkaline Water Company Inc. (NASDAQ and CSE: WTER) (the “Company”), a producer of bottled alkaline water, flavored-infused waters, and CBD-infused products sold under the brand names Alkaline88®, A88 Infused™, and A88CBD™, respectively. The Company today announced that its hemp-derived cannabidiol brand A88CBD™ is partnering with consumer brands agency, C.A. Fortune.“A88CBD™ is growing rapidly, and we are excited for this partnership with C.A. Fortune so we can continue expanding the brand’s retail footprint,” stated Richard Wright, President and CEO of The Alkaline Water Company. “A88CBD™ boasts all-natural ingredients with a high-quality hemp-derived CBD formulation. C.A. Fortune works as one of the leading national brokers in the organic and all-natural space, and A88CBD™...

Continue reading

INmune Bio, Inc. Prices Public Offering of Common Stock

LA JOLLA, Calif, July 16, 2020 (GLOBE NEWSWIRE) —  INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, today announced today the pricing of its  underwritten public offering of an aggregate of 2,173,914 shares of its common stock at a public offering price of $10.00 per share.   In addition, INmune has granted the underwriters an over-allotment option, exercisable for 45 days from today to purchase up to an additional 326,086 shares of common stock at the public offering price, less the underwriting discounts and commissions.  The offering is expected to close on or about July 20, 2020, subject to customary closing conditions.The gross proceeds to INmune from this offering are expected to...

Continue reading

American River Bankshares Reports Second Quarter 2020 Results

SACRAMENTO, Calif., July 16, 2020 (GLOBE NEWSWIRE) — American River Bankshares (NASDAQ-GS: AMRB) today reported net income of $1.7 million, or $0.30 per diluted share for the second quarter of 2020 compared to $1.3 million, or $0.22 per diluted share for the second quarter of 2019.  For the six months ended June 30, 2020, net income was $3.2 million or $0.54 per diluted share, compared to $2.4 million or $0.41 per diluted share for the six months ended June 30, 2019.“As one would expect, the second quarter 2020 was significantly impacted by the COVID-19 pandemic.  Much of our activity was focused on addressing the issues caused by the pandemic,” said David E. Ritchie, Jr., President and Chief Executive Officer. “Our priority was keeping our staff and clients safe and helping our clients navigate this crisis through loan deferrals...

Continue reading

Atossa Therapeutics Contracts for Clinical Study of AT-301 Nasal Spray, Atossa’s Second COVID-19 Therapeutic Development Program

SEATTLE, July 16, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced that it has contracted with Avance Clinical Pty Ltd to conduct a clinical study of Atossa’s proprietary drug candidate AT-301, to be administered by nasal spray. Avance is a leading Australian clinical research organization and has successfully completed multiple clinical studies of Atossa’s proprietary Endoxifen.AT-301 is Atossa’s proprietary formula intended for nasal administration in patients immediately following diagnosis of COVID-19 but who have not yet exhibited symptoms severe enough to require hospitalization. It is intended for at-home use...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.